Skip to main content
low healthVERIFIED

TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitation

Verified: 2 outlets have reported this story since Nov 22.

📍 London, GB·🕐 4h ago·2 outlets

How sure are we

✓ Verified · 2 outlets

Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.

How we count · Check a link someone shared

Who reported it

The story so far · 2 reports · ✓ Verified Nov 22, 5:57 PM UTC
  1. Nov 22, 4:46 PM UTCFirst report
    Venus Medtech (Hangzhou) Inc.: TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitationfinanznachrichten.de ↗
  2. Nov 22, 5:57 PM UTC+1 h· you’re reading this
    TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitationprnewswire.com ↗
  3. Verified: a second independent outlet reported itNov 22, 5:57 PM UTC · +1 h
Location
Verification Log

No verification data yet

Checks run automatically as new sources are ingested.

Discussion (0)

Sign in to join the discussion

No discussion yet — be the first to add context.

Reliability
81%

Very high · How we score this

Risk Score
low risk